Concorde Asset Management’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-7,999
Closed -$206K – 211
2021
Q1
$206K Buy
+7,999
New +$210K 0.12% 199

Other funds holding IBD

Concorde Asset Management's IBD Position: Q2 2021 in Review

Concorde Asset Management sold out of Inspire Corporate Bond ETF (IBD) in Q2 2021, closing a stake of 7,999 shares — an estimated $206K sold.

Concorde Asset Management first reported a position in IBD in Q1 2021 and held it in 1 quarter. The position peaked at $206K in Q1 2021. 39 funds tracked by Wall St. Rank hold IBD as of Q2 2021.

  • Concorde Asset Management reported no remaining Inspire Corporate Bond ETF position as of Q2 2021 after selling out during the quarter.
  • Concorde Asset Management sold 7,999 Inspire Corporate Bond ETF shares in Q2 2021, an estimated $206K.
  • Concorde Asset Management first reported a position in Inspire Corporate Bond ETF in Q1 2021 and held it in 1 quarter.
  • Concorde Asset Management's Inspire Corporate Bond ETF position peaked at $206K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2021.

Based on Concorde Asset Management's 13F filing for Q2 2021, filed 20 Jul 2021.